EurekaMag.com logo
+ Translate

A multicenter, open-label extension study of gabapentin monotherapy in pediatric patients with benign epilepsy with centrotemporal spikes


, : A multicenter, open-label extension study of gabapentin monotherapy in pediatric patients with benign epilepsy with centrotemporal spikes. Epilepsia 37(SUPPL 5): 111


(PDF 0-2 workdays service)

Accession: 029685285

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Hes, M.S.; Trudeau, V.L.; Kilgore, M.B.; Poulter, C.J.; Garofalo, E.A.; Koto, E.P.; 94/95, U.S.G.p Study Group, 1995: A double-blind, placebo-controlled, randomized multicenter trial of GABAPENTIN in pediatric patients with benign childhood epilepsy with centrotemporal spikes. Epilepsia 36(SUPPL 4): 125

Bourgeois, B.; Brown, L.W.; Pellock, J.M.; Buroker, M.; Greiner, M.; Garofalo, E.A.; Schimschock, J.R.; Griesemer, D.; Bebin, M.E.; Murphy, J.V., 1998: Gabapentin monotherapy in children with benign childhood epilepsy with centrotemporal spikes A 36-week, double-blind, placebo-controlled study. Epilepsia 39(SUPPL 6): 163

Coppola, G.; Franzoni, E.; Verrotti, A.; Garone, C.; Sarajlija, J.; Operto, F.Felicia.; Pascotto, A., 2006: Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. To evaluate the efficacy and tolerability of levetiracetam or oxcarbazepine as monotherapy in children with newly diagnosed benign epilepsy with centrotemporal spikes (BECTS). Twenty-one children (11 males, 10 females), aged between 5 and 13 years...

Anhut, H.; Greiner, M.J.; Alexander, J.; Murray, G.; 78/178, I.G.p Study Group, 1997: Gabapentin monotherapy compared with carbamazepine An international open-label multicenter study in patients with newly diagnosed epilepsy. Epilepsia 38(SUPPL 8): 92

Crockatt, J.G.; Leiderman, D.B.; Malicsi, M.J.R.; Garofalo, E.A.; 88 89, T.U.G.p Study Group, 1995: Open-label, follow-on study of Gabapentin monotherapy in patients with refractory epilepsy. Epilepsia 36(SUPPL 4): 69

Garofalo, E.A.; Hayes, A.G.; Greeley, C.A.; Hes, M.S.; Mann, M.E.; Pierce, M.W.; 82/83, T.U.G.p Study Group, 1995: An open-label extension study of GABApentin monotherapy in patients with medically refractory partial seizures. Epilepsia 36(SUPPL 4): 68

Hyayes, A.; Hes, M.; Mann, M.; Garofalo, E.; Leiderman, D.B.; Pierce, M., 1994: An open-label multicenter study of gabapentin monotherapy and safety in medically refractory patients with partial seizures. Neurology 44(4 SUPPL 2): A204

Rating, D.; Wolf, C.; Bast, T., 2000: Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: A 6-month randomized, double-blind, placebo-controlled study. Purpose: To evaluate the efficacy and tolerability of sulthiame (STM) as monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS). Methods: Sixty-six BECTS patients entered a 6-month double-blind trial and were ran...

Hayes, A.; Mann, M.; Greeley, C.; Hes, M.; Spring, P.; Garofalo, E.; Leiderman, D.; Pierce, M.; 82/83, T.U.G.bapentin Study Group, 1994: An ongoing open-label multicenter study evaluating gabapentin monotherapy and safety in patients with medically refractory partial seizures. Epilepsia 35(SUPPL 8): 164

Tzitiridou, M.; Panou, T.; Ramantani, G.; Kambas, A.; Spyroglou, K.; Panteliadis, C., 2005: Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation. We report on 70 patients (aged 5.2-11.6 years) newly diagnosed with benign childhood epilepsy with centrotemporal spikes (BECTS) who were assigned to oxcarbazepine (OXC) monotherapy. All of them underwent clinical and electroencephalographic exami...